CRISPR technology

GPTKB entity

Statements (67)
Predicate Object
gptkbp:instance_of gptkb:physicist
gptkbp:bfsLayer 3
gptkbp:bfsParent gptkb:Emmanuelle_Charpentier
gptkb:University
gptkb:DJ
gptkb:Harvard_University
gptkb:Jennifer_Doudna
gptkb:CRISPR_Therapeutics
gptkb:Mario_Capecchi
gptkbp:allows gene replacement
gene insertion
gene knockout
targeted gene modification
gptkbp:based_on gptkb:CRISPR-Cas9
bacterial immune system
gptkbp:business_model biodiversity loss
designer babies
gene editing in humans
gptkbp:challenges traditional breeding methods
conventional genetic engineering
gptkbp:developed_by gptkb:Emmanuelle_Charpentier
gptkb:Jennifer_Doudna
gptkbp:engages_in personalized medicine
vaccine development
therapeutic applications
pathogen research
gptkbp:future_plans improve food security
cure genetic diseases
enhance crop resilience
create new therapies
gptkbp:has_programs gptkb:item
genetic disorders
cancer research
agricultural improvements
https://www.w3.org/2000/01/rdf-schema#label CRISPR technology
gptkbp:is gptkb:political_movement
gptkbp:is_criticized_for unintended consequences
ethical implications
potential misuse
gptkbp:is_part_of molecular biology
modern genetics
biomedical research
synthetic biology research
gptkbp:is_promoted_by gptkb:Research_Institute
biotechnology companies
research institutions
gptkbp:is_studied_in gptkb:healthcare_organization
gptkb:cystic_fibrosis
gptkb:sickle_cell_disease
gptkb:DJ
gptkb:psychologist
HIV treatment
various cancers
gptkbp:is_supported_by pharmaceutical companies
government funding
venture capitalists
Cas9 protein
guide RNA
gptkbp:is_used_in clinical trials
agricultural biotechnology
gptkbp:regulates government agencies
ethical committees
gptkbp:used_in gptkb:hospital
gptkb:Company
agriculture
genome editing
gene editing